0

514336

GENESIS

img img img img
No Data Available

GENESIS IBRC INDIA LIMITED Share Price Update

As of the latest trading session, GENESIS IBRC INDIA LIMITED share price is currently at ₹75, which is up by ₹2.62 from its previous closing. Today, the stock has fluctuated between ₹75.00 and ₹75.99. Over the past year, GENESIS IBRC INDIA LIMITED has achieved a return of 308.94%. In the last month alone, the return has been 0.49%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GENESIS IBRC INDIA LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    97.50

  • P/E Ratio (TTM)

    -416.67

  • Beta

    0.28

  • Book Value / share

    6.42

  • Return on equity

    32.01%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -0.03

info icon alternate text

GENESIS IBRC INDIA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit -0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.06
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.12
Net Profit -0.12
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.09
EBITDA -0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit -0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 3.67
Operating Expense 0.16
Net Profit 3.50
Net Profit Margin (%) 95.36
Earnings Per Share (EPS) 2.70
EBITDA 3.50
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 3.80
Net Profit -3.80
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -2.92
EBITDA -3.80
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit -0.14
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.11
EBITDA -0.14
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.12
Net Profit -0.12
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.09
EBITDA -0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.12
Net Profit -0.12
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.09
EBITDA -0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2018 (Values in Cr)
Book Value / Share 7.39
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.15
EBITDA Margin 4.39
Particulars MAR 2025 (Values in Cr)
Book Value / Share 6.56
ROE % 32.01
ROCE % 32.01
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 6.79
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 6.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 6.98
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 12.29
Total Liabilities 12.29
Total Equity 9.60
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) -0.27
Return on Capital (%) -0.35
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 8.83
Total Liabilities 8.83
Total Equity 8.53
Share Outstanding 1
Price to Book Ratio 2.80
Return on Assets (%) 39.66
Return on Capital (%) 41.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 5.20
Total Liabilities 5.20
Total Equity 5.02
Share Outstanding 1
Price to Book Ratio 3.37
Return on Assets (%) -72.90
Return on Capital (%) -75.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 8.96
Total Liabilities 8.96
Total Equity 8.82
Share Outstanding 1
Price to Book Ratio 1.57
Return on Assets (%) -1.53
Return on Capital (%) -1.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 9.09
Total Liabilities 9.09
Total Equity 8.96
Share Outstanding 1
Price to Book Ratio 1.35
Return on Assets (%) -1.28
Return on Capital (%) -1.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 9.20
Total Liabilities 9.20
Total Equity 9.07
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) -1.26
Return on Capital (%) -1.28
Particulars MAR 2018 (Values in Cr)
Net Income -0.19
Cash from Operations 1.68
Cash from Investing -4.65
Cash from Financing 3.00
Net change in Cash 0.02
Free Cash Flow 1.68
Particulars MAR 2025 (Values in Cr)
Net Income 3.50
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2024 (Values in Cr)
Net Income -3.79
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income -0.13
Cash from Operations -0.09
Cash from Investing 0.00
Cash from Financing 0.08
Net change in Cash 0.00
Free Cash Flow -0.09
Particulars MAR 2022 (Values in Cr)
Net Income -0.11
Cash from Operations -0.11
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.11
Particulars MAR 2021 (Values in Cr)
Net Income -0.11
Cash from Operations -0.12
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.12
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7611.10 60.25 12.04 109435.94 6002.15 / 8099.00
FORTIS MALAR HOSPITALS LIMITED 54.60 22.56 2.97 102.33 52.24 / 98.70
SHREE PACETRONIX LTD. 130.00 19.20 2.91 47.77 61.11 / 283.15
TRANSGENE BIOTEK LTD. 2.54 0.00 2.09 19.25 1.83 / 5.26
VIMTA LABS LIMITED 470.10 34.52 6.12 2098.30 372.50 / 902.85
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7611.10 75.35 11.74 109435.94 6002.15 / 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 / 0.0
CHENNAI MEENAKSHI MULTISPECIAL 43.69 0.00 -12.69 32.64 28.34 / 57.48
KOVAI MEDICAL CENTER & HOSPITA 5303.40 24.60 4.87 5801.92 4810.20 / 6725.00

GENESIS IBRC INDIA LIMITED shareholding pattern

Holding

88.66%
11.33%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

GENESIS IBRC INDIA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
75.00 3.61 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 71.40
  • 26 Days 78.40
  • 10 Days 72.60
  • 50 Days 85.70
  • 12 Days 73.40
  • 100 Days 86.40
  • 20 Days 76.30
  • 200 Days 70.90
72.38 PIVOT

First Support

72.38

First Resistance

72.38

Second Support

72.38

Second Resistance

72.38

Third Support

72.38

Third Resistance

72.38

RSI

45.58

ADX

18.57

MACD

-4.98

Williams % R

-65.07

Commodity Channel Index (CCI)

-29.57

Date

2026-02-20

Week

835.00

Same Day

1022.00

Month

568.00

1 Year

0.28

3 Year

0.36

Over 1 Month

0.49%

down

Over 1 Year

308.94%

down

Over 3 Months

-53.56%

down

Over 3 Years

91.43%

down

Over 6 Months

97.16%

down

Over 5 Years

58.65%

down

GENESIS IBRC INDIA LIMITED Corporate Actions

Top Gainers

GENESIS IBRC INDIA LIMITED Share Price

Genesis IBRC India Limited was formerly incorporated as Fine Plast Polymers Limited in October, 1992. Thereafter, the name of the Company was changed from Fine Plast Polymers Limited to SSK Lifestyles Limited in October, 2014 and further was changed from SSK Lifestyles Limited to Genesis IBRC India Limited in January, 2018. Promoted by P M Rao, P Janardhana Rao, P Rama Rao and their Associates, the Company came out with a public issue in Dec.'93 to part-finance the setting up of its plant in Pamur, Andhra Pradesh. The plant has an installed capacity of 432 tpa for rigid PVC pipes and 778 tpa for PVC fittings.

Initially, Company manufactured rigid PVC pipes and fittings like tees, elbows, adopters, reducers, end caps, etc. used in agriculture and agro-based activities like sprinkler irrigation systems, process piping, oil and gas and shipping industries. At present, it is engaged in the business areas of biotechnology and/or pro-biotic products.

In 1994, the company signed an MoU with the Andhra Pradesh Industrial and Technical Consultancy Organisation to market its pipes and also to arrange for lucrative joint ventures in the Gulf.

During 1996-97, the company has installed capacity of its PVC Pipe Fittings capactiy from 1338 MTS to 1858 MTS, for which IDBI has sanctioned a Term Loan of Rs 3.60 crores.

In the year under review i.e. 1999-2000, due working capital problems the performance of the company was unsatisfactory and is taking all steps to improve its performance.

In 2014-15, the Company diversified its business operations by venturing into trading in lifestyle products. The name of Company was changed to 'SSK Lifestyles Limited' with effect from 29 October 2014.

During the year 2017-18, the Company acquired 100% shareholding of Genesis I.B.R.C. Private Limited' and accordingly, the said Company became the wholly owned subsidiary of the Company with effect from 24th June 2017. Similarly, M/s. Genesis I.B.R.C. Private Limited' the wholly owned subsidiary of the Company acquired Genesis Biosciences IBRC' a partnership firm engaged in manufacturing and marketing of pro-biotic products for aquaculture and fisheries.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Genesis IBRC India Ltd?

Answer Field

Genesis IBRC India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 75.00 as on Feb 20 2026 12:52 PM.

What is the Market Cap of Genesis IBRC India Ltd Share?

Answer Field

The market cap of Genesis IBRC India Ltd for NSE ₹ 0.00 & for BSE ₹ 97.50 as on Feb 20 2026 12:52 PM.

What is the 52 Week High and Low of Genesis IBRC India Ltd?

Answer Field

The 52 Week High and Low of Genesis IBRC India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 184.90 and ₹ 18.34.

What is 1 year return for Genesis IBRC India Ltd?

Answer Field

The 1 year returns on the stock has been 308.94%.

What is the P/E Ratio of Genesis IBRC India Ltd Share?

Answer Field

As on Feb 20 2026 12:52 PM the price-to-earnings (PE) ratio for Genesis IBRC India Ltd share is -416.67.

What is the PB ratio of Genesis IBRC India Ltd Share?

Answer Field

As on Feb 20 2026 12:52 PM, the price-to-book (PB) ratio for Genesis IBRC India Ltd share is 6.42.

How to Buy Genesis IBRC India Ltd Share?

Answer Field

You can trade in Genesis IBRC India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Genesis IBRC India Ltd Share on Bajaj Broking App?

Answer Field

To buy Genesis IBRC India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Genesis IBRC India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59